Saw Palmetto Efficacy For BPH Symptoms Slated For NIH Clinical Study
This article was originally published in The Tan Sheet
Executive Summary
Three NIH divisions plan to spend a combined $29 mil. over the next seven years to study the efficacy of saw palmetto and Pygeum africanum on relieving symptoms associated with benign prostatic hyperplasia
You may also be interested in...
Saw Palmetto, BPH Study Backed By $1.6 Mil. In NIDDK Funding
Researchers at the University of California-San Francisco expect to complete enrollment for a study on the effects of saw palmetto in alleviating symptoms of benign prostatic hyperplasia (BPH) in June
Saw Palmetto, BPH Study Backed By $1.6 Mil. In NIDDK Funding
Researchers at the University of California-San Francisco expect to complete enrollment for a study on the effects of saw palmetto in alleviating symptoms of benign prostatic hyperplasia (BPH) in June
Saw Palmetto, BPH Study Backed By $1.6 Mil. In NIDDK Funding
Researchers at the University of California-San Francisco expect to complete enrollment for a study on the effects of saw palmetto in alleviating symptoms of benign prostatic hyperplasia (BPH) in June